Global Needle-Free Drug Injection Systems Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Needle-Free Drug Injection Systems market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Needle-Free Drug Injection Systems market."
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.

Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.

The global Needle-Free Drug Injection Systems market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Needle-Free Drug Injection Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Needle-Free Drug Injection Systems market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Antares Pharma, Inc. (US)
    Endo International plc (US)
    PharmaJet (U.S)
    Bioject Medical Technologies Inc. (U.S)
    Medical International Technology, Inc. (U.S)
    INJEX Pharma AG (Germany)
    National Medical Products Inc. (US)
    Valeritas, Inc. (US)
    European Pharma Group (Netherland)
    PenJet Corporation (U.S)
    Crossject SA (France)

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Jet-Based Needle-Free Injectors
    Spring-Based Needle-Free Injectors
    Laser-Powered Needle-Free Injectors
    Vibration-Based Needle-Free Injectors

Segment by Application
    Hospitals and Clinics
    Homecare Settings
    Research Laboratories
    Pharmaceutical and Biotechnology companies
    Other End Users